Download PDF
CC BY-NC-ND 4.0 · Thromb Haemost 2023; 123(03): 347-361
DOI: 10.1055/a-1980-8852
Stroke, Systemic or Venous Thromboembolism

Genetic Predisposition of Both Waist Circumference and Hip Circumference Increased the Risk of Venous Thromboembolism

Jiayu Wang‡   *
1   Department of Cardiology, The Second Hospital of Shandong University, Jinan, China
,
Jiangshan Tan‡   *
2   Key Laboratory of Pulmonary Vascular Medicine, National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
,
Lu Hua
2   Key Laboratory of Pulmonary Vascular Medicine, National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
,
Qiping Sheng
1   Department of Cardiology, The Second Hospital of Shandong University, Jinan, China
,
Xianwei Huang
3   Department of Emergency, The First Affiliated Hospital of Xiamen University, Xiamen, China
,
Ping Liu
1   Department of Cardiology, The Second Hospital of Shandong University, Jinan, China
› Author Affiliations Funding This study and this research group were supported by grants from the Science and Technology Innovation Project of Jinan City (No. 201602153; No. 202019193), the Major Research and Development Project of Shandong Province (No. ZR2020MH041), the Natural Fund Project of Shandong Province (No. G201703080074), the project of the Central Government Guides Local Science and Technology Development (2021Szvup073), the National Natural Science Foundation of China (No. 81170274; No. 82170462), and the National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences (NCRC2020007).
› Further Information
Also available at
   Permissions and Reprints


Abstract

Background Obesity, especially abdominal obesity, is an independent indicator of increased cardiovascular risk. Observational studies have shown an observational association between obesity and venous thromboembolism (VTE). As a type of VTE, pulmonary embolism (PE) is also associated with obesity. However, it is unclear whether the observed associations are causal or caused by confounding bias or reverse causality.

Methods We performed a two-sample test by obtaining the exposure dataset of waist circumference (WC) and hip circumference (HC) from the Neale Laboratory Consortium's genome-wide association study summary data and the summary-level outcome data of VTE and PE from FinnGen Biobank of European ancestry to determine the causal effect of WC and HC on VTE and PE.

Results All three Mendelian randomization methods displayed a positive association between WC/HC and VTE/PE. WC and HC were positively associated with VTE (odds ratio [OR] = 1.803 per 1 standard deviation [SD] increase in WC, 95% confidence interval [CI] = 1.393–2.333; p < 0.001; OR = 1.479 per 1 SD increase in HC, 95% CI = 1.219–1.796; p < 0.001, respectively). Furthermore, we found a causal association between genetically predicted WC/HC and a higher risk of PE (OR = 1.929 per 1 SD increase in WC, 95% CI = 1.339–2.778, p < 0.001; OR = 1.431 per 1 SD increase in HC, 95% CI =1.095–1.869; p = 0.009, respectively).

Conclusion There is a significant causal relationship between WC/HC and VTE/PE, which is consistent with observational studies. Taking measures to reduce WC/HC of obesity may help reduce the incidence of VTE/PE.

Keywords

waist circumference - hip circumference - venous thromboembolism - Mendelian randomization study - obesity

Contribution to the Field Statement

Obesity, especially abdominal obesity, is an independent indicator of increased cardiovascular risk. There have been observational studies that showed an observational association between obesity and venous thromboembolism. As a type of venous thromboembolism, pulmonary embolism is also associated with obesity. But it is unclear whether the observed association is causal or caused by confounding bias or reverse causality. To verify and compare the effects of waist circumstance and hip circumstance on venous thromboembolism and life-threatening pulmonary embolism, we used the method of Mendelian randomization study to analysis the exposure data from the Neale Laboratory Consortium's GWAS summary data and the summary-level outcome data from FinnGen Biobank of European ancestry. Then we found a causal association between genetically predicted waist circumstance/hip circumstance and higher risk of pulmonary embolism, and compared with hip circumstance, waist circumstance is a better anthropometric index to predict venous thromboembolism in obese patients. This conclusion is consistent with observational studies. But compared with observational studies, our findings provide evidence of significant causality between waist circumstance/hip circumstance and venous thromboembolism/pulmonary embolism. Based on the above conclusions, we make the case that taking measures to reduce waist circumstance/hip circumstance of obesity may help reduce the incidence of venous thromboembolism.


Author Contributions

Project design and interpretation: J.T. and P.L.; data curation: J.T. and J.W.; statistical analysis: J.T.; methodology: J.T. and P.L.; validation: P.L., Q.S., and X.H.; writing—original draft: J.T. and J.W.; review, revision, and editing: P.L., J.T., and L.H. All authors have read and agreed to the published version of the manuscript.


* These authors have contributed equally to this work and share authorship.


Supplementary Material



Publication History

Received: 25 June 2022

Accepted: 11 November 2022

Accepted Manuscript online:
16 November 2022

Article published online:
05 January 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Weitz JI, Chan NC. Novel antithrombotic strategies for treatment of venous thromboembolism. Blood 2020; 135 (05) 351-359
    CrossrefPubMedSearch in Google Scholar
  • 2 Bledsoe JR, Woller SC, Stevens SM. et al. Management of low-risk pulmonary embolism patients without hospitalization: the low-risk pulmonary embolism prospective management study. Chest 2018; 154 (02) 249-256
    CrossrefPubMedSearch in Google Scholar
  • 3 Hodeib H, Youssef A, Allam AA. et al. Genetic risk profiling associated with recurrent unprovoked venous thromboembolism. Genes (Basel) 2021; 12 (06) 874
    CrossrefPubMedSearch in Google Scholar
  • 4 Keller K, Wöllner J, Schmitt VH. et al. Risk factors for pulmonary embolism in patients with paralysis and deep venous thrombosis. J Clin Med 2021; 10 (22) 5412
    CrossrefPubMedSearch in Google Scholar
  • 5 Gervaso L, Dave H, Khorana AA. Venous and arterial thromboembolism in patients with cancer: JACC: CardioOncology state-of-the-art review. JACC CardioOncol 2021; 3 (02) 173-190
    CrossrefPubMedSearch in Google Scholar
  • 6 Stewart LK, Kline JA. Metabolic syndrome increases risk of venous thromboembolism recurrence after acute deep vein thrombosis. Blood Adv 2020; 4 (01) 127-135
    CrossrefPubMedSearch in Google Scholar
  • 7 Maners J, Gill D, Pankratz N. et al; CHARGE Inflammation Working Group, INVENT Consortium, MEGASTROKE consortium of the International Stroke Genetics Consortium (ISGC). A Mendelian randomization of γ′ and total fibrinogen levels in relation to venous thromboembolism and ischemic stroke. Blood 2020; 136 (26) 3062-3069
    CrossrefPubMedSearch in Google Scholar
  • 8 Cavallari I, Morrow DA, Creager MA. et al. Frequency, predictors, and impact of combined antiplatelet therapy on venous thromboembolism in patients with symptomatic atherosclerosis. Circulation 2018; 137 (07) 684-692
    CrossrefPubMedSearch in Google Scholar
  • 9 Borch KH, Braekkan SK, Mathiesen EB. et al. Anthropometric measures of obesity and risk of venous thromboembolism: the Tromso study. Arterioscler Thromb Vasc Biol 2010; 30 (01) 121-127
    CrossrefPubMedSearch in Google Scholar
  • 10 Kim MS, Kim WJ, Khera AV. et al. Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies. Eur Heart J 2021; 42 (34) 3388-3403
    CrossrefPubMedSearch in Google Scholar
  • 11 Lindström S, Germain M, Crous-Bou M. et al; INVENT Consortium. Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study. Hum Genet 2017; 136 (07) 897-902
    CrossrefPubMedSearch in Google Scholar
  • 12 Yuan S, Bruzelius M, Xiong Y, Håkansson N, Åkesson A, Larsson SC. Overall and abdominal obesity in relation to venous thromboembolism. J Thromb Haemost 2021; 19 (02) 460-469
    CrossrefPubMedSearch in Google Scholar
  • 13 Tan JS, Liu NN, Guo TT, Hu S, Hua L. Genetically predicted obesity and risk of deep vein thrombosis. Thromb Res 2021; 207: 16-24
    CrossrefPubMedSearch in Google Scholar
  • 14 Richmond RC, Hemani G, Tilling K, Davey Smith G, Relton CL. Challenges and novel approaches for investigating molecular mediation. Hum Mol Genet 2016; 25 (R2): R149-R156
    CrossrefPubMedSearch in Google Scholar
  • 15 Lawlor DA. Commentary: Two-sample Mendelian randomization: opportunities and challenges. Int J Epidemiol 2016; 45 (03) 908-915
    CrossrefPubMedSearch in Google Scholar
  • 16 Hemani G, Zheng J, Elsworth B. et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife 2018; 7: e34408
    CrossrefPubMedSearch in Google Scholar
  • 17 Rapid GWAS of thousands of phenotypes for 337,000 samples in the UK Biobank—Nealelab.. Accessed July 18, 2019 at: http://www.nealelab.is/blog/2017/7/19/rapid-gwas-of-thousands-of-phenotypes-for-337000-samples-in-the-uk-biobank
    PubMed
  • 18 MR-Base. Accessed February 12, 2022 at: http://app.mrbase.org/
    PubMed
  • 19 Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 2013; 37 (07) 658-665
    CrossrefPubMedSearch in Google Scholar
  • 20 Larsson SC, Bäck M, Rees JMB, Mason AM, Burgess S. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study. Eur Heart J 2020; 41 (02) 221-226
    CrossrefPubMedSearch in Google Scholar
  • 21 Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology 2017; 28 (01) 30-42
    CrossrefPubMedSearch in Google Scholar
  • 22 Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015; 44 (02) 512-525
    CrossrefPubMedSearch in Google Scholar
  • 23 Burgess S, Dudbridge F, Thompson SG. Re: “Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects”. Am J Epidemiol 2015; 181 (04) 290-291
    CrossrefPubMedSearch in Google Scholar
  • 24 Xu L, Borges MC, Hemani G, Lawlor DA. The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study. Diabetologia 2017; 60 (11) 2210-2220
    CrossrefPubMedSearch in Google Scholar
  • 25 Liu N, Tan J-S, Liu L, Wang Y, Hua L, Qian Q. Genetic predisposition between COVID-19 and four mental illnesses: a bidirectional, two-sample Mendelian randomization study. Front Psychiatry 2021; 12: 746276
    CrossrefPubMedSearch in Google Scholar
  • 26 Broadbent JR, Foley CN, Grant AJ, Mason AM, Staley JR, Burgess S. MendelianRandomization v0.5.0: updates to an R package for performing Mendelian randomization analyses using summarized data. Welcome Open Res 2020; 5: 252
    CrossrefPubMedSearch in Google Scholar
  • 27 Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 2018; 50 (05) 693-698
    CrossrefPubMedSearch in Google Scholar
  • 28 Obaid M, El-Menyar A, Asim M, Al-Thani H. Prevalence and outcomes of thrombophilia in patients with acute pulmonary embolism. Vasc Health Risk Manag 2020; 16: 75-85
    CrossrefPubMedSearch in Google Scholar
  • 29 Hotoleanu C. Genetic risk factors in venous thromboembolism. Adv Exp Med Biol 2017; 906: 253-272
    CrossrefPubMedSearch in Google Scholar
  • 30 Romano AVC, Barnabé A, Gadelha TB. et al. Gene variants associated with venous thrombosis: a replication study in a Brazilian multicentre study. Clin Appl Thromb Hemost 2020; 26: 1076029620962225
    CrossrefPubMedSearch in Google Scholar
  • 31 Middeldorp S. Inherited thrombophilia: a double-edged sword. Hematology (Am Soc Hematol Educ Program) 2016; 2016 (01) 1-9
    CrossrefPubMedSearch in Google Scholar
  • 32 Morimont L, Haguet H, Dogné JM, Gaspard U, Douxfils J. Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk. Front Endocrinol (Lausanne) 2021; 12: 769187
    CrossrefPubMedSearch in Google Scholar
  • 33 Ahmad A, Sundquist K, Palmér K, Svensson PJ, Sundquist J, Memon AA. Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model. J Thromb Thrombolysis 2019; 47 (02) 216-226
    CrossrefPubMedSearch in Google Scholar
  • 34 Evensen LH, Arnesen CAL, Rosendaal FR. et al. The Risk of Venous Thromboembolism Attributed to Established Prothrombotic Genotypes. Thromb Haemost 2022; 122 (07) 1221-1230
    Thieme ConnectPubMedSearch in Google Scholar
  • 35 Powell-Wiley TM, Poirier P, Burke LE. et al; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2021; 143 (21) e984-e1010
    PubMedSearch in Google Scholar
  • 36 Cushman M, O'Meara ES, Heckbert SR, Zakai NA, Rosamond W, Folsom AR. Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: the longitudinal investigation of thromboembolism etiology. Thromb Res 2016; 144: 127-132
    CrossrefPubMedSearch in Google Scholar
  • 37 Hagan KA, Harrington LB, Kim J. et al. Adiposity throughout the life course and risk of venous thromboembolism. Thromb Res 2018; 172: 67-73
    CrossrefPubMedSearch in Google Scholar
  • 38 Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjønneland A, Overvad K. Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation 2009; 120 (19) 1850-1857
    CrossrefPubMedSearch in Google Scholar
  • 39 Stefan N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol 2020; 8 (07) 616-627
    CrossrefPubMedSearch in Google Scholar
  • 40 Deguchi H, Banerjee Y, Elias DJ, Griffin JH. Elevated CETP lipid transfer activity is associated with the risk of venous thromboembolism. J Atheroscler Thromb 2016; 23 (10) 1159-1167
    CrossrefPubMedSearch in Google Scholar
  • 41 Onida S, Tan MKH, Kafeza M. et al. Metabolic phenotyping in venous disease: the need for standardization. J Proteome Res 2019; 18 (11) 3809-3820
    CrossrefPubMedSearch in Google Scholar
  • 42 Salobir B, Sabovic M. A metabolic syndrome independent association between overweight, fibrinolysis impairment and low-grade inflammation in young women with venous thromboembolism. Blood Coagul Fibrinolysis 2006; 17 (07) 551-556
    CrossrefPubMedSearch in Google Scholar
  • 43 Schwartz GG, Steg PG, Szarek M. et al; ODYSSEY OUTCOMES Committees and Investigators*. Peripheral artery disease and venous thromboembolic events after acute coronary syndrome: role of lipoprotein(a) and modification by alirocumab: prespecified analysis of the ODYSSEY OUTCOMES randomized clinical trial. Circulation 2020; 141 (20) 1608-1617
    CrossrefPubMedSearch in Google Scholar
  • 44 Caiano LM, Costanzo S, Panzera T. et al; Moli-sani Study Investigators. Association between body mass index, waist circumference, and relative fat mass with the risk of first unprovoked venous thromboembolism. Nutr Metab Cardiovasc Dis 2021; 31 (11) 3122-3130
    CrossrefPubMedSearch in Google Scholar
  • 45 Giordano NJ, Jansson PS, Young MN, Hagan KA, Kabrhel C. Epidemiology, pathophysiology, stratification, and natural history of pulmonary embolism. Tech Vasc Interv Radiol 2017; 20 (03) 135-140
    CrossrefPubMedSearch in Google Scholar
  • 46 Cao W, Li X, Zhang X. et al. No causal effect of telomere length on ischemic stroke and its subtypes: a Mendelian randomization study. Cells 2019; 8 (02) 159
    CrossrefPubMedSearch in Google Scholar
  • 47 Kaze AD, Bigna JJ, Nansseu JR, Noubiap JJ. Body size measures and risk of venous thromboembolism: protocol for a systematic review and meta-analysis. BMJ Open 2018; 8 (03) e018958
    CrossrefPubMedSearch in Google Scholar
  • 48 White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 2009; 123 (Suppl 4): S11-S17
    CrossrefPubMedSearch in Google Scholar
  • 49 Tan JS, Yan XX, Wu Y. et al. Rare variants in MTHFR predispose to occurrence and recurrence of pulmonary embolism. Int J Cardiol 2021; 331: 236-242
    CrossrefPubMedSearch in Google Scholar
  • 50 Tan JS, Ren JM, Fan L. et al. Genetic predisposition of anti-cytomegalovirus immunoglobulin G levels and the risk of 9 cardiovascular diseases. Front Cell Infect Microbiol 2022; 12: 884298
    CrossrefPubMedSearch in Google Scholar